Vision Loss After SJS: Options for California Victims

Understanding SJS/TEN and why vision can be affected

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but serious conditions involving skin and mucous membranes; medications are a commonly reported trigger. Because the ocular surface (including the conjunctiva and cornea) is mucosal tissue, the eyes can be involved during the acute illness and in the months or years that follow. See: MedlinePlus (SJS/TEN) and AAO EyeWiki (Stevens-Johnson Syndrome).

Some patients experience ongoing complications after hospitalization, ranging from chronic irritation to scarring and corneal damage that can affect visual acuity. For general medical background, see: PubMed review on ocular involvement and management in SJS/TEN.

Common eye complications reported after SJS/TEN

Every case is different, and severity varies. Ocular issues described in clinical resources and reviews include:

• Eye pain, burning, or light sensitivity (photophobia)
• Severe dry eye and tear-film instability
• Conjunctival scarring or adhesions
• Corneal epithelial defects, ulceration, scarring, or vascularization
• Eyelid margin problems (including misdirected lashes) or incomplete eyelid closure
• Recurrent inflammation or infection

From both a medical and legal perspective, documenting how symptoms evolve, what improves, what persists, and what procedures or medications are required can matter.

When vision loss may support a legal claim (and when it may not)

Not every severe drug reaction indicates wrongdoing, and SJS/TEN can occur even with appropriate care. Vision loss may raise legal questions, however, when the reaction may have been preventable or when reasonable steps to reduce harm may not have been taken.

Depending on the facts, an investigation may focus on issues such as:

• Whether a medication associated with SJS/TEN risk was prescribed or dispensed without appropriate counseling or consideration of contraindications
• Whether a known allergy or prior severe reaction history was overlooked
• Whether early warning signs (for example, rash with systemic symptoms or mucous membrane involvement) were not recognized and the suspected medication was continued
• Whether delays in escalation, ophthalmology involvement, or hospital care may have contributed to worse ocular outcomes
• Whether the manufacturer’s warnings or instructions were adequate for the intended prescribing context (a fact-intensive inquiry that often turns on expert review)

Case evaluation typically examines what was known (or reasonably should have been known) at the time and whether different actions were more likely than not to have changed the outcome.

Who might be responsible in California (depending on the facts)

Liability is fact-specific. In California, potential parties that may be evaluated include:

• Drug manufacturers (for example, product liability theories such as failure to warn)
• Prescribers (potential professional negligence/medical malpractice, depending on the clinical scenario)
• Pharmacies/pharmacists (for example, dispensing errors; in some situations, questions may also arise about counseling obligations)
• Hospitals/clinics (for example, delays in triage/escalation, monitoring, or specialist referral)

More than one party may be involved. Sorting this out usually requires a detailed timeline, complete records, and qualified expert input.

Key evidence that often matters in SJS vision-injury cases

SJS/TEN cases are typically documentation-heavy. Evidence that often matters includes:

• Complete medication history (start/stop dates, dose changes, refills, and pharmacy records)
• Symptom timeline (first rash/fever, mouth/eye symptoms, and when care was sought)
• Photographs (if available) showing progression
• ER/urgent care/hospital records (including consults, discharge summaries, medication administration records, and nursing notes)
• Ophthalmology records (slit-lamp findings, corneal involvement, scarring, procedures, and follow-up plans)
• Diagnostic workup notes (what else was considered or ruled out)
• Functional-impact documentation (work restrictions, low-vision services, assistive devices, and daily-activity limitations)

Tip: preserve evidence without delaying care

Checklist: what to gather for a California SJS/TEN vision-loss review

Timing considerations in California

California deadlines depend on the type of claim and the defendants involved, and they can be affected by discovery rules and other exceptions. Examples that may apply include:

• General personal injury: typically two years (California Code of Civil Procedure section 335.1: CCP 335.1).
• Medical malpractice: generally three years from injury or one year from discovery, whichever occurs first, subject to statutory details and exceptions (California Code of Civil Procedure section 340.5: CCP 340.5).
• Public-entity involvement: a government claim may need to be presented within six months of accrual for personal injury (California Government Code section 911.2: Gov. Code 911.2).

Because vision complications may develop or stabilize over time, it is often important to consult counsel promptly to preserve records and evaluate deadlines.

FAQ

Should I wait until my vision stabilizes before talking to a lawyer?

Often, no. Even if treatment is ongoing, early review can help preserve records, identify key timelines, and avoid preventable deadline issues.

Do I need proof of exactly which drug caused SJS/TEN to start an evaluation?

Not always. A review typically starts with the medication and symptom timeline, then considers medical documentation and expert analysis to assess likely causation.

What if my doctor said SJS/TEN is a known risk and unavoidable?

Some reactions are not preventable, but a legal review may still examine warnings, contraindications, counseling, and whether symptoms were recognized and acted on promptly.

Can more than one party be responsible?

Yes. Depending on the facts, a case may involve manufacturers, prescribers, pharmacies, and healthcare facilities.

Call to action

If you want a California-focused, record-based review of an SJS/TEN vision-loss situation, contact us.

Disclaimer: This content is general information, not legal advice or medical advice, and it does not create an attorney-client relationship. Deadlines and legal duties can be fact-dependent and may change; consult a California-licensed attorney for advice about your situation. If you have possible SJS/TEN symptoms or worsening vision, seek urgent medical care.